← Research library

Effect of bemethyl on glycogen metabolism in hepatocytes of diseased human liver

Comparison in people · 2002

What was studied
Hepatocyte measurements from patients with chronic hepatitis and cirrhosis
Main finding
Reports changes in glycogen content and composition versus basic therapy. Structural liver abnormalities persisted and metabolic indices did not normalize.

Glycogen decrease versus glucose-6-phosphatase activity · r = 0.75 · p<0.05

Reported findings and study design

Hepatocyte glycogen analysis in patients with chronic hepatitis or cirrhosis; Bemitil compared with basic treatment.

Population or model Hepatocyte measurements from patients with chronic hepatitis and cirrhosis

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Glycogen decrease versus glucose-6-phosphatase activityr = 0.75p<0.05
Glycogen decrease versus pretreatment glycogen levelr = 0.87p<0.01
Metabolic normalizationNot completeStructural liver abnormalities also persisted

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Biochemical measures are not survival, fibrosis reversal or confirmed clinical recovery.
  • Allocation, sample size and clinical endpoints need the full paper.

Source details

Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.

Sources checked

Citation

Human comparative studyEnglish abstract

M. V. Kudriavtseva, N. N. Bezborodkina, S. V. Okovityi, O. V. Ivanova, B. N. Kudriavtsev. Effect of bemethyl on glycogen metabolism in hepatocytes of diseased human liver Tsitologiia. 44(7):668–675. PMID 12455377

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards